High Resolution C-13 MRI With Hyperpolarized Urea: Mapping and N-15 Labeling Effects.

IEEE transactions on medical imaging 10/2013; 33(2). DOI: 10.1109/TMI.2013.2285120
Source: PubMed


C steady state free precession (SSFP) magnetic resonance imaging and effective spin-spin relaxation time (T2) mapping were performed using hyperpolarized [13C]urea and [13C;15 N2]urea injected intravenously in rats. 15N labeling gave large T2 increases both in solution and in vivo due to the elimination of a strong scalar relaxation pathway. The T2 increase was pronounced in the kidney, with [13C;15 N2]urea giving T2 values of 6:31:3 s in the cortex and medulla, and 112 s in the renal pelvis. The measured T2 in the aorta was 1:3 0:3 s. [13C]urea showed shortened T2 values in the kidney of 0:23 0:03 s compared to 0:28 0:03 s measured in the aorta. The enhanced T2 of [13C;15 N2]urea was utilized to generate large signal enhancement by SSFP acquisitions with flip angles approaching the fully refocused regime. Projection images at 0.94 mm in-plane resolution were acquired with both urea isotopes, with [13C;15 N2]urea giving a greater than four-fold increase in SNR over [13C]urea.

22 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: PurposeHyperpolarized 13C magnetic resonance allows for the study of real-time metabolism in vivo, including significant hyperpolarized 13C lactate production in many tumors. Other studies have shown that aggressive and highly metastatic tumors rapidly transport lactate out of cells. Thus, the ability to not only measure the production of hyperpolarized 13C lactate but also understand its compartmentalization using diffusion-weighted MR will provide unique information for improved tumor characterization.Methods We used a bipolar, pulsed-gradient, double spin echo imaging sequence to rapidly generate diffusion-weighted images of hyperpolarized 13C metabolites. Our methodology included a simultaneously acquired B1 map to improve apparent diffusion coefficient (ADC) accuracy and a diffusion-compensated variable flip angle scheme to improve ADC precision.ResultsWe validated this sequence and methodology in hyperpolarized 13C phantoms. Next, we generated ADC maps of several hyperpolarized 13C metabolites in a normal rat, rat brain tumor, and prostate cancer mouse model using both preclinical and clinical trial-ready hardware.ConclusionADC maps of hyperpolarized 13C metabolites provide information about the localization of these molecules in the tissue microenvironment. The methodology presented here allows for further studies to investigate ADC changes due to disease state that may provide unique information about cancer aggressiveness and metastatic potential. Magn Reson Med, 2014. © 2014 Wiley Periodicals, Inc.
    Magnetic Resonance in Medicine 09/2014; 74(3). DOI:10.1002/mrm.25422 · 3.57 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this work we demonstrate for the first time directly detected manganese-55 (55Mn) MRI using a clinical 3T MRI scanner designed for human hyperpolarized 13C clinical studies with no additional hardware modifications. Due to the similar frequency of the 55Mn and 13C resonances, the use of aqueous permanganate for large, signal-dense, and cost-effective “13C” MRI phantoms was investigated, addressing the clear need for new phantoms for these studies. Due to 100% natural abundance, higher intrinsic sensitivity, and favorable relaxation properties, 55Mn MRI of aqueous permanganate demonstrates dramatically increased sensitivity over typical 13C phantom MRI, at greatly reduced cost as compared with large 13C-enriched phantoms. A large sensitivity advantage (22-fold) was demonstrated. A cylindrical phantom (d = 8 cm) containing concentrated aqueous sodium permanganate (2.7M) was scanned rapidly by 55Mn MRI in a human head coil tuned for 13C, using a balanced SSFP acquisition. The requisite penetration of RF magnetic fields into concentrated permanganate was investigated by experiments and high frequency electromagnetic simulations, and found to be sufficient for 55Mn MRI with reasonably sized phantoms. A sub-second slice-selective acquisition yielded mean image SNR of ~ 60 at 0.5cm3 spatial resolution, distributed with minimum central signal ~ 40% of the maximum edge signal. We anticipate that permanganate phantoms will be very useful for testing HP 13C coils and methods designed for human studies.
    Magnetic Resonance Imaging 12/2014; 32(10). DOI:10.1016/j.mri.2014.08.030 · 2.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Imaging of hyperpolarized nuclei provides significant new insights into previously inaccessible aspects of disease biology. Many of the biomolecules crucial for understanding and monitoring metabolism are present in low concentration and are often beyond the detection threshold of traditional magnetic resonance spectroscopy and imaging. A solution is to improve sensitivity by a factor of 10 000 or more by temporarily redistributing the populations of nuclear spins in a magnetic field, a process termed hyperpolarization. Nuclei such as 13C in metabolically active biomolecules can be hyperpolarized, providing unprecedented gains in sensitivity for imaging biologic compounds. Although the first US National Cancer Institute-sponsored white paper describing the potential of this new molecular imaging technique was published only 3 years ago, over 60 biomolecules have been polarized and tested in preclinical studies. Moreover, a phase 1 clinical trial of hyperpolarized [1-13C]pyruvate in prostate cancer patients has demonstrated that this powerful technology can be translated to the clinic. This review is focused on the dissolution dynamic nuclear polarization (DNP)-based polarization technique and summarizes the acquisition techniques used for hyperpolarized 13C imaging, in vivo applications of some of the most promising hyperpolarized 13C labeled biomolecules, and its clinical translation.Keywords:hyperpolarized dissolution dynamic nuclear polarization (DNP);carbon-13 magnetic resonance imaging (MRI);13C magnetic resonance spectroscopic imaging (MRSI);pyruvate;lactate;metabolic imaging;molecular imaging
    eMagRes, 12/2014: pages 311-324; , ISBN: 9780470058213
Show more